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Abstract
Phospholamban functions as a regulator of Ca
2+ concentration of cardiac muscle cells by triggering the bioactivity of
sarcoplasmic reticulum Ca
2+-ATPase. In order to understand its dynamic mechanism in the environment of bilayer
surroundings, we performed long time-scale molecular dynamic simulations based on the high-resolution NMR structure of
phospholamban pentamer. It was observed from the molecular dynamics trajectory analyses that the conformational
transitions between the ‘‘bellflower’’ and ‘‘pinwheel’’ modes were detected for phospholamban. Particularly, the two modes
became quite similar to each other after phospholamban was phosphorylated at Ser16. Based on these findings, an
allosteric mechanism was proposed to elucidate the dynamic process of phospholamban interacting with Ca
2+-ATPase.
Citation: Lian P, Wei D-Q, Wang J-F, Chou K-C (2011) An Allosteric Mechanism Inferred from Molecular Dynamics Simulations on Phospholamban Pentamer in
Lipid Membranes. PLoS ONE 6(4): e18587. doi:10.1371/journal.pone.0018587
Editor: Darren R. Flower, Aston University, United Kingdom
Received August 28, 2010; Accepted March 10, 2011; Published April 15, 2011
Copyright:  2011 Lian et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the grants from Chinese National Basic Research Program (973 Program, No. 2011CB707500), Chinese National
Comprehensive Technology Platforms for Innovative Drug R&D (No. 2009ZX9301-007), Chinses National Science Foundation (No. 30870476), and Shanghai
Natural Science Foundation (No. 10ZR1421500). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dqwei@sjtu.edu.cn (DQW); jfwang8113@sjtu.edu.cn (JFW)
Introduction
Phospholamban (PLN) is a 52-residue integral membrane
protein that functions as a regulator of Ca
2+ concentration of
cardiac muscle cells by triggering the bioactivity of sarcoplasmic
reticulum Ca
2+-ATPase (SERCA) [1,2]. Binding of PLN to
SERCA can inhibit the SERCA Ca
2+ pump activity so as to
decrease the Ca
2+ concentration within the cell, further leading the
reduction of the relaxation rate of heart muscle cells [3,4].
However, the inhibition will lost after PLN is phosphorylated at
position 16 or 17 by cAMP- or calmodulin-dependent protein
kinases, resulting in the dissolution of PLN/SERCA complex or
an altered interaction between the two proteins [5,6]. Based on a
link between PLN mutations and heart failure in humans, it is
found that the alteration of PLN inhibitory function can lead to
degenerative cardiomyopathy [7,8]. Thus, for its regulation of
heart contractions in heart muscle cells, PLN has been of
considerable interest as a potential target for the treatment of
degenerative cardiac diseases.
With an aim of understanding the inhibitory mechanism of
PLN, many studies have begun with the structural behaviors of
PLN in the membrane or other solvents without SERCA. As
reported, more than 75% of PLN in the membranes adopt the
pentameric form [9,10]. However, most experimental evidences
support the fact that the inhibition of SERCA is primarily involved
in the monomeric form of PLN rather than the pentameric form
[11,12,13]. Thus, most of the theoretical and experimental studies
of PLN are focused on the monomeric form of PLN [14,15,
16,17,18,19,20]. It is noted that the monomeric PLN has three
distinct structural domains: a short cytoplasmic (CP) helices (also
called domain Ia or cytoplasmic domain, residues 1–16), a hinge
with a b-turn type III conformation (residues 17–22), as well as a
long hydrophobic transmembrane (TM) helix that is composed of
domain Ib (residues 23–30) and domain II (residues 31–52)
[21,22]. Further investigations with multidimensional solid-state
NMR and hybrid solution NMR give an indication that the CP
and TM helices adopt angles of 93–102u and 22–24u respectively
with respect to the lipid normal [17,22]. Additionally, the
pentameric PLN is reported to be able to form an ion channel
for Ca
2+ and Cl
- [23,24]. Also, the pentameric form is considered
to be capable of storing the monomeric form, revealing a
mechanism for the cell to control inhibition of Ca
2+-ATPase [25].
By now, the bellflower and pinwheel models are of general
acceptance to be the structural models for pentameric PLN. The
former is a high-resolution NMR structure determined by James J.
Chou and his co-workers with PDB entry 1zll [26,27]. In the
bellflower model, PLN pentamer shows a pore-forming coiled-coil
structure with the TM helices remarkably bending away from the
channel pore near the cytoplasmic side. The latter is a theoretical
model (PDB entry 1xnu) obtained from the Forster resonance
energy transfer measurements [28]. In this model, TM helices are
less bended compared with the bellflower model, and the
cytoplasmic helices are located in the plane of the membranes.
Although several MD studies of partial or full length PLN in
different environments have been reported [15,18,19,20,
29,30,31], most of these studies are only focused on the
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the pentameric PLN. However, the one published by Kim et al.
[30] only used the bellflower models, while the other [31] did not
consider the phosphorylated PLN at all. In view of this, the present
study was initiated to use all-atom molecular dynamics (MD)
simulations to study the conformational dynamics of both
bellflower and pinwheel models of PLN pentamer as well as their
phosphorylated forms in POPC bilayer surroundings, so as to gain
the atomistic insights into the internal motion [32,33] of PLN
pentamer and its functions. Similar approaches have been
successfully used to investigate various problems related to protein
structure [34,35,36,37,38,39], protein-protein interactions and
protein-drug interactions [40,41,42,43], as well as drug design
[44,45,46,47].
Materials and Methods
The initial coordinates for the bellflower and pinwheel models
of PLN pentamer were taken from the RCSB Protein Data Bank
[48] with PDB entries 1zll [26] and 1xnu [28], respectively. Based
on the atomic coordinates of the bellflower structure (1zll), the
following four initial systems were generated for MD simulation
studies: (i) monomeric PLN as denoted by PLN
bf-mono; (ii)
pentameric PLN denoted by PLN
bf-penta; (iii) phosphorylated
PLN monomer denoted by pPLN
bf-mono; (iv) phosphorylated PLN
pentamer denoted by pPLN
bf-penta. Likewise, based on the atomic
coordinates of the pinwheel structure (1xnu), the following four
initial systems were generated: (i) monomeric PLN as denoted by
PLN
pw-mono; (ii) pentameric PLN denoted by PLN
pw-penta; (iii)
phosphorylated PLN monomer denoted by pPLN
pw-mono; (iv)
phosphorylated PLN pentamer denoted by pPLN
pw-penta.
Before performing MD simulations, the aforementioned eight
systems were merged with a patch of a pre-equilibrated membrane
with 256 POPC bilayers, and subsequently solvated in TIP3P
water molecules [49]. Meanwhile, sodium ions were randomly
placed to neutralize the simulated systems. Subsequently, 150,000-
step energy minimization was performed on water molecules and
ions for the monomeric systems using conjugate gradient and line
search algorithm to remove energetically unfavorable contacts.
Another 50,000 steps were added for the pentameric systems
because of their larger sizes. In this procedure, both of the proteins
and lipids were fixed. Then, all the systems were heated to 310 K
over 500 ps by velocity rescaling, and equilibrated for 4 ns in the
NPT ensemble with all non-hydrogen atoms of the protein and
POPC membranes harmonically restrained. The equilibration was
continued for another 10 ns with the harmonic restrain applied to
the protein backbone only. Finally, the systems obtained at the end
of the aforementioned equilibrations were used for the further
unrestrained 40-ns MD simulations. As the simulated systems may
be far too large to expect the statistical convergence in 40-ns MD
simulations, we have done some repeats with different starting
structures and starting vectors. Thus, for each simulation, at least
10 MD trajectories with different starting vectors were generated.
All the MD simulations involved in this study were performed by
NADM 2.6 package [50] with the CHARMM27 force field
parameters [51], periodic boundary conditions,and NPTensemble.
SHAKE algorithm with a tolerance of 10
26 A ˚ was used to constrain
all bonds involved with hydrogen atoms. The Nose ´-Hoover
Langevin piston pressure control and Langevin damping dynamics
were employed to keep the simulated systems at a constant pressure
of 1 atmosphere and a constant temperature of 310 K [52,53]. The
long-range electrostatic interactions were evaluated by particle
mesh Ewald (PME) method [54] with the size of the grid at about
1A ˚. The vander Waals interactions were treated by using a cutoff of
12A ˚. All the simulations were performed with a time step of 1fs, and
the coordinates were saved every 1ps.
Figure 1. Global properties for the MD simulations. (A) Time dependent RMS fluctuations of all the C
a atoms, (B) Definitions of the angle h and
distance d, (C) Time dependent angle h value, and (D) Time dependent distance d value. The black, green, red, and blue curves stand for pinwheel
PLN, bellflower PLN, pinwheel pPLN, and bellflower pPLN, respectively.
doi:10.1371/journal.pone.0018587.g001
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Global properties
As a crucial criterion for the convergence measure of the protein
systems concerned, the root mean square (RMS) deviation from
the initial structures of the C
a atoms for both bellflower and
pinwheel models of pentameric and monomeric PLN and pPLN
systems were calculated. Both bellflower and pinwheel models of
pentameric PLN and pPLN systems underwent various confor-
mational changes during our 40-ns MD simulations. For the
bellflower models, the overall RMS deviation value for PLN was
around 7.5260.68 A ˚, while that for pPLN was 7.5061.21 A ˚. For
the pinwheel model, the overall RMS deviation value for PLN was
8.2961.45 A ˚, while that for pPLN was 9.6761.61 A ˚. There was a
difference of about 1 A ˚ for the overall RMS deviations between
the two models in PLN, indicating that the pinwheel model was
more flexible, and involved with larger conformational changes. It
is interesting to note that the phosphorylation at Ser16 remarkably
enhanced this kind of difference to around 1.4 A ˚. In view of this, it
is very likely that the phosphorylation could play a role in
increasing the flexibility of both structural models.
However, such RMS differences are really small for a
biomacromolecular system. One possible explanation for this
observation is that most residues of PLN have little conformational
changes. As aforementioned, PLN monomer has three distinct
structural domains: a short cytoplasmic domain (domain Ia), a
hinge with a b-turn type III conformation, and a long hydrophobic
transmembrane domain (domain Ib and II). The long transmem-
brane domain, which occupies almost 60% residues of PLN
monomer, is inserted into the lipid bilayer with little room for large
amplitude fluctuations. Therefore, the transmembrane domain has
little contributions to the RMS differences. In other words, the
major contributions to the RMS differences were from the
cytoplasmic and the b-turn, which contain much less residues than
the transmembrane domain. To further confirm this, we
calculated the RMS fluctuation values for each residue in both
bellflower and pinwheel models of pentameric PLN and pPLN
systems. The results are shown in Fig. 1A, from which we can see
that for both the bellflower and pinwheel models, the RMS
fluctuation values in the transmembrane regions were almost the
same. However, the diversity was detected at the position of
res.10–20 that was situated outside of the bilayers, belonging to the
cytoplasmic domain where the phosphorylation occurred.
Structure and dynamics of the cytoplasmic domain
In order to study the structural and dynamic diversity of the
cytoplasmicdomain,inFig.1Bwedefined anangleh todescribethe
direction of the cytoplasmic domain to the POPC bilayers, and a
distance d to describe the distance of the cytoplasmic domain with
the POPC bilayers. Based on the 10 independent simulations for
each simulated system (40-ns MD trajectories), time averages were
used to compute expectation values for the angle h and distance d.
Following similar analyses by some theoretical studies [55,56],
bootstrap-style sampling-with-replacement approach was adopted
to generate new re-sampled datasets for each simulation trajectory,
each of which was used to estimate average values for the angle h
and distance d. The distribution of these average values over all re-
sampled dataset for all the MD trajectories was subsequently
employed to estimate the variability of the angle h and distance d,
and also to calculate variances and confidence intervals.
Figure 2. The crystal structures of the bellflower and pinwheel
models for the pentameric PLN. (A) In the bellflower model, PLN
assumes ‘‘R’’-state configuration, and (B) in the pinwheel model, PLN
assumes ‘‘L’’-state configuration.
doi:10.1371/journal.pone.0018587.g002
Figure 3. Structural transitions between the ‘‘R’’ and ‘‘L’’ states.
In this snapshot figure, only one subunit of the pentamer is shown for
the bellflower model (green) and pinwheel model (red), respectively.
doi:10.1371/journal.pone.0018587.g003
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domain with the lipid bilayer. The first and last residues in the
cytoplasmic domain were used to determine a line, which was
further used to determine the angle h. With the development of
simulation along time, the h value for the bellflower model was
about 41.1968.46 degrees, while that for the pinwheel model was
about 23.4067.46 degrees (Fig. 1C). The differences in the h value
indicated that bellflower and pinwheel structures assumed quite
different conformations in the cytoplasmic domain: the former was
extended to the region away from the bilayers, while the latter
bended to near the bilayers. However, after phosphorylation at
Ser16, both the two models shared a similar h value (about 30
degrees,), indicating that the two were with quite the same
configurations due to the phosphorylation effect.
It can be seen from Fig. 1D that the d value for the bellflower
model was about 30.0061.19 A ˚, while that for the pinwheel model
was about 33.7262.40 A ˚. After phosphorylation at Ser16, the
distance d for both models increased: for the bellflower structure, it
was increased from 30 A ˚ to 32 A ˚; for the pinwheel mode, it was
increased from 32 A ˚ to 37 A ˚. These evidences further indicate that
phosphorylation at Ser16 could enhance the flexibility of PLN as
mentioned above. This finding is also quite consistent with the
NMR study in DPC micelles [14] and previous MD simulations
[18,19,20,30].
Structural transition in the cytoplasmic domain
The structural differences in the bellflower and pinwheel models
are mainly located in the cytoplasmic domain. In general, the
bellflower structure assumes an extended appearance; while the
pinwheel model assumes a bent conformation having more
interactions with the bilayers (Fig. 2). The cytoplasmic helices in
the bellflower assembly are oriented at ,20 degrees with respect to
the bilayers, while the ones in the pinwheel assembly are ,90
degrees. It is intriguing to have observed the structural transitions
between the two models via our MD simulations. As shown in
Fig. 3, for the bellflower model, although the initial structure was
in the ‘‘extended’’ state (h value is 57.43 degrees, and d value is
32.23 A ˚), after 21-ns simulations it became the ‘‘bent’’ state (h
value is 24.95 degrees, and d value is 31.86 A ˚) as shown in the
pinwheel model. Likewise, for the pinwheel model, similar
Figure 4. A proposed allosteric model for the regulation mechanism of SERCA by PLN. In this figure, the membrane and PLN are
represented by rectangles and colored in gray and blue, respectively. SERCA is shown in blue boxes. The arrows in black show the formation of
SERCA-PLN complex. The gray arrows are for the phosphorylation and dephosphorylation. Reactions shown with red arrows are the processes we
found in this study. Phosphoric group is represented by the red dotted circle.
doi:10.1371/journal.pone.0018587.g004
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original ‘‘bent’’ conformation (h value is 16.91 degrees, and d value
is 42.28 A ˚) to the ‘‘extended’’ one (h value is 39.34 degrees, and d
value is 30.57 A ˚). These findings were also supported by the
experimental results that both extended and bent states of PLN
have been readily detected in the micelles and lipid bilayers using
electron paramagnetic resonance (EPR) spectroscopy [57,58].
Further analyses of chemical shift perturbation for the PLN-
SERCA complex showed clear evidences for the structural
transition between the extended and bent states [57,59].
In the pPLN systems, the conformations from both the
bellflower structure and pinwheel structure look almost the same.
As shown in Fig.1C, after 20-ns MD simulations the angle h values
for both pPLN systems are 30.8769.93 degrees (bellflower model)
and 27.3769.05 degrees (pinwheel model). One possible expla-
nation for this observation is that phosphorylation can increase the
interactions of PLN with the lipid bilayer, resulting in the fact that
the cytoplasmic domain no longer moves as freely as the
unphosphorylated structure. Thus, after phosphorylation at
Ser16, both models have to adopt a similar configuration, which
is also supported by the previous theoretical studies [19,20].
Accordingly, our theoretical studies supported the allosteric
model to elucidate the interactions between PLN and SERCA, as
illustrated in Fig. 4. According to the allosteric model, there is a
dynamic equilibrium between the ‘‘extended’’ and ‘‘bent’’
conformations for PLN in the free form. The major difference
between the extended and bent states for PLN is located on the
cytoplasmic domain. For the extended state of PLN (bellflower
model), the cytoplasmic domain is in a dynamically disordered
state in which the central part of this domain is unfolded. For the
bent state of PLN (pinwheel model), this domain employs an
ordered state. Both models can interact with SERCA, forming
transition and active states respectively. Only the bellflower
structure with the ‘‘extended’’ conformation can form a thermo-
dynamically more stable complex (active state) with SERCA so as
to inhibit the activity of Ca
2+ pump. This is because the bent state
of PLN is not propitious for the SERCA binding by the reason that
the cytoplasmic domain in this state is much close to the lipid, far
away from SERCA. Owing to the disordered structure, the
extended state of PLN can be extended above the lipid surface and
interact with SERCA.
However the phosphorylation at Ser16 reduces the structural
difference between the PLN monomer in bellflower model and
that in pinwheel model, revealing a structural transition between
the ordered and disordered states in the cytoplasmic domain. This
order-to-disorder or disorder-to-order transition can influence the
conformational equilibrium between the bent and extended states
of PLN monomers. Specifically, phosphorylation can shift the
conformational equilibrium towards the extended state via a
cooperative effect [60]. Furthermore, the phosphorylation at
Ser16 can also inactive the SERCA-PLN complex, independent of
it bding in either the transition state or in the active state, by
disrupting the interactions between SERCA and PLN. According
to the experimental and theoretical studies, a crucial hydrogen
bond formed by PLN (Gln26) and SERCA (Arg234) maybe lost.
In this case, the activity of Ca
2+ pump is recovered. Interestingly,
the dephosphorylation of Ser16 may drive PLN to the original
equilibrium again so as to make the regulation cycle move on.
Using the allosteric model, our findings show for the first time how
the two different conformations of PLN monomer are produced.
The results of this study also reveal the mechanism of SERCA
Ca
2+ pump’s regulation by PLN.
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